Diabetology
Home – Diabetology
Diabetology
Care for Better Control
At Arkyen Pharmaceuticals, our diabetology portfolio focuses on the management of Type 2 diabetes and related metabolic needs. We offer therapeutic options designed to help healthcare professionals address individual patient requirements and contribute to better long-term diabetes care.
Our Diabetology Portfolio
Focused on Diabetes Care
A focused portfolio of pharmaceutical solutions for Type 2 diabetes and related metabolic needs, developed to address diverse treatment requirements across ongoing diabetes care.
Empazept-M
Diabetic Care
Blood Sugar Control
Empagliflozin 12.5 mg + Metformin Hydrochloride 500 mg tablets for Type 2 Diabetes Mellitus, helping improve blood sugar control and insulin sensitivity.
Dapalize-10
Diabetic Care
Blood Sugar Control
Dapagliflozin 10 mg tablets for Type 2 Diabetes Mellitus, helping improve glycemic control while supporting weight management and cardiovascular and renal health.
Dapalize-Trio LD
Diabetic Care
Blood Sugar Control
Dapagliflozin 5 mg + Sitagliptin 50 mg + Metformin Hydrochloride 500 mg (ER) tablets for Type 2 Diabetes Mellitus, helping improve HbA1c and support metabolic control.
Sitalize-M 50/500
Diabetic Care
Glycemic Control
Sitagliptin + Metformin tablets for Type 2 Diabetes Mellitus, helping improve glycemic control when diet, exercise, or monotherapy is insufficient.
Sitalize-50
Diabetic Care
Glycemic Control
Committed to advancing healthcare through quality pharmaceutical solutions, meaningful partnerships, and a growing portfolio across diverse therapeutic areas.
Our Divisions
Quick Links
Designed & Develped by NKONNECT GLOBAL VENTURES